Key points
- The National Agency for Food and Drug Administration and Control (NAFDAC) has launched a pharmacovigilance safety audit across Kwara State healthcare facilities.
- State Coordinator Mariam Issa-Onilu confirmed that the exercise aligns directly with the parameters of the Nigeria National Pharmacovigilance Policy and Implementation Framework 2020.
- Specialized field inspections will audit the structural setup of hospital Pharmacovigilance Committees and their channels for tracking Adverse Drug Reactions (ADRs).
- The Kwara State Ministry of Health has pledged full administrative support, granting NAFDAC access to local broadcast media slots to drive public awareness.
- The regulatory exercise focuses on improving automated signal detection, clinical risk management, and multi-stakeholder collaboration to curb medicine-related injuries.
Main Story
The National Agency for Food and Drug Administration and Control (NAFDAC) has finalized plans to execute a comprehensive safety assessment across all public and private healthcare facilities in Kwara State.
The clinical regulation initiative was announced by the State Coordinator of NAFDAC, Mrs. Mariam Issa-Onilu, during a high-level courtesy visit to the leadership of the Kwara State Ministry of Health in Ilorin. This field exercise aims to entrench strict pharmacovigilance protocols, the specialized branch of medical science dedicated to spotting, tracking, and preventing severe adverse reactions associated with pharmaceutical drugs and vaccine administration.
According to regulatory briefs, the state-wide inspection framework is designed to satisfy the strict requirements of the Nigeria National Pharmacovigilance Policy and Implementation Framework 2020. Inspectors deployed to various medical centers will closely examine the internal operations and administrative strength of localized Pharmacovigilance Committees.
Specifically, the regulatory audit will cross-check how hospitals document unexpected clinical complications, manage drug risk signals, and collaborate with central health databases to guarantee that substandard or toxic medicines are swiftly pulled from circulation.
Receiving the regulatory delegation, the Permanent-Secretary of the Kwara State Ministry of Health, Dr. Taoheed Abdullahi, backed the exercise and emphasized that strengthening internal hospital safety committees is critical to preserving public health.
To ensure long-term compliance, provincial health authorities have urged NAFDAC to scale up its grassroots enlightenment campaigns through targeted media sensitizations, community outreach, and the distribution of educational literature. To jumpstart this mass communication drive, the ministry has officially cleared NAFDAC to feature on its specialized “Health Gist” broadcast platform to educate the public on how to identify and report adverse drug events.
The Issues
- Modernizing irregular and manual hospital reporting channels to ensure immediate tracking of Adverse Drug Reactions (ADRs).
- Overcoming widespread public under-reporting of medicine-related complications by building accessible community channels.
- Enhancing the clinical capacity of local hospital committees to identify complex pharmaceutical risk signals early.
What’s Being Said
- Outlining the operational blueprint and core auditing benchmarks for the clinical safety exercise, the State Coordinator of NAFDAC, Mrs. Mariam Issa-Onilu, stated: “The assessment would focus on the structure and functionality of Pharmacovigilance Committees, reporting channels for Adverse Drug Reactions (ADRs), risk management and signal detection processes, as well as collaboration between PVC units and other stakeholders,”.
What’s Next
- NAFDAC field inspectors will begin rolling out on-site evaluations of specialized safety committees within Kwara State hospitals.
- The Agency will distribute educational posters and flyers across regional health centers to improve public literacy on drug side-effects.
- NAFDAC communications teams will debut on the state ministry’s “Health Gist” program to break down protocols for reporting bad drug reactions.
Bottom Line
NAFDAC is launching an extensive drug-safety audit across Kwara healthcare facilities in line with the national pharmacovigilance policy, partnering with the state health ministry to improve risk monitoring and public reaction reporting.
 has finalized plans to execute a ...){kind=link}